IL100241A - 6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing it - Google Patents
6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing itInfo
- Publication number
- IL100241A IL100241A IL10024191A IL10024191A IL100241A IL 100241 A IL100241 A IL 100241A IL 10024191 A IL10024191 A IL 10024191A IL 10024191 A IL10024191 A IL 10024191A IL 100241 A IL100241 A IL 100241A
- Authority
- IL
- Israel
- Prior art keywords
- adenosine
- hydrate
- methyl
- cyclohexyl
- myocardial infarction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4039060A DE4039060A1 (de) | 1990-12-07 | 1990-12-07 | Neue kristallform |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL100241A0 IL100241A0 (en) | 1992-09-06 |
| IL100241A true IL100241A (en) | 1995-12-08 |
Family
ID=6419797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10024191A IL100241A (en) | 1990-12-07 | 1991-12-05 | 6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing it |
Country Status (9)
| Country | Link |
|---|---|
| DE (1) | DE4039060A1 (OSRAM) |
| FI (1) | FI915734L (OSRAM) |
| IL (1) | IL100241A (OSRAM) |
| NO (1) | NO178545C (OSRAM) |
| NZ (1) | NZ240873A (OSRAM) |
| PL (1) | PL166094B1 (OSRAM) |
| SG (1) | SG44937A1 (OSRAM) |
| TW (1) | TW224050B (OSRAM) |
| ZA (1) | ZA919658B (OSRAM) |
-
1990
- 1990-12-07 DE DE4039060A patent/DE4039060A1/de not_active Withdrawn
-
1991
- 1991-12-05 SG SG1996009727A patent/SG44937A1/en unknown
- 1991-12-05 NO NO914779A patent/NO178545C/no not_active IP Right Cessation
- 1991-12-05 NZ NZ240873A patent/NZ240873A/xx unknown
- 1991-12-05 FI FI915734A patent/FI915734L/fi not_active Application Discontinuation
- 1991-12-05 IL IL10024191A patent/IL100241A/en not_active IP Right Cessation
- 1991-12-06 ZA ZA919658A patent/ZA919658B/xx unknown
- 1991-12-06 PL PL91292665A patent/PL166094B1/pl unknown
- 1991-12-07 TW TW080109606A patent/TW224050B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| IL100241A0 (en) | 1992-09-06 |
| TW224050B (OSRAM) | 1994-05-21 |
| FI915734A0 (fi) | 1991-12-05 |
| NO178545C (no) | 1996-04-17 |
| PL166094B1 (pl) | 1995-03-31 |
| DE4039060A1 (de) | 1992-06-11 |
| NO914779D0 (no) | 1991-12-05 |
| PL292665A1 (en) | 1992-12-14 |
| FI915734A7 (fi) | 1992-06-08 |
| NZ240873A (en) | 1993-09-27 |
| SG44937A1 (en) | 1997-12-19 |
| ZA919658B (en) | 1993-06-27 |
| NO178545B (no) | 1996-01-08 |
| NO914779L (no) | 1992-06-09 |
| FI915734L (fi) | 1992-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0490818B1 (en) | 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof | |
| CA2155673C (en) | N-alkyl-2-substituted atp analogues | |
| HU226057B1 (en) | N6 heterocyclic substituted adenosine derivatives, their use for production of pharmaceutical compositions and pharmaceutical compositions containing them | |
| IL100241A (en) | 6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing it | |
| HU198950B (en) | Process for producing new furanuronic acid derivatives and pharmaceutical compositions comprising such compounds | |
| IT8948640A1 (it) | Derivati dell'adenosina, loro preparazione e loro impiego come medicamenti. (caso 100-7409) | |
| CA1092510A (en) | Compositions containing 5'-amino-5' deoxythymidine and pharmaceutically acceptable salts thereof | |
| CA1088944A (en) | Nitric ester of n-(2-hydroxyethyl)nicotinamide and a process for the preparation of same | |
| US5153180A (en) | Fluorinated nucleosides and process for treating retrovirus infections therewith | |
| EP0266504A2 (en) | Use of N6-[(1,2-dihydro-1-acenaphthylenyl) methyl]-adenosine in the preparation of pharmaceutical compounds for treating congestive heart failure | |
| SK146096A3 (en) | Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them | |
| HRP920648A2 (en) | New crystalline form | |
| JP3773148B2 (ja) | 虚血性疾患予防、治療剤及び臓器保存剤 | |
| US4439442A (en) | Naftidrofuryl citrate and therapeutic applications | |
| CN116874557B (zh) | 2-Trp-AA-四氢咔啉-3-羧酸类化合物及其PAF抑制剂的应用 | |
| EP0291594B1 (en) | Pyrazine for use in the treatment of haemodynamic and metabolic disorders | |
| Nowak et al. | Vascular effects of infused adenosine are not mediated by prostacyclin release in humans | |
| Leone Jr et al. | Adenosine deaminase and BW A1433U attenuate hypoxia-induced ventricular ectopy | |
| MXPA96005046A (en) | Derivatives of adenos | |
| SK13192A3 (sk) | Použitie 2'-0-alkyladenozínových derivátov na prípravu liečiva vhodného na liečenie neúrode generatívnych porúch | |
| Kannan et al. | Lack of Effect of 3, 3′ 5’-Triiodothyronine (Reverse T3) on Cardiac Function in the Rabbit | |
| Erlemeier et al. | Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol | |
| Schulz et al. | Hypotensive and antiplatelet actions of motapizone depend on dose and time after ingestion | |
| WO1995022968A1 (en) | δ-(S-METHYLISOTHIOUREIDO)-L-NORVALINE AND CEREBROVASCULAR DISORDER REMEDY HAVING NITROGEN MONOXIDE SYNTHASE INHIBITOR ACTIVITY | |
| CA2421067A1 (en) | Adenosine derivatives and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| HC | Change of name of proprietor(s) | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |